Clinical Trial Update: Role of Salbutamol and Furosemide in TTN [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the roles of salbutamol and furosemide in treating Transient Tachypnea of the Newborn. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Tachypnea of the Newborn

Drugs mentioned

• FUROSEMIDE (Furosemide)
• Salbutamol (salbutamol)

Snippet

Sponsor: Armed Forces Hospital, Pakistan | Conditions: Transient Tachypnea of the Newborn | Phase 3 | Status: COMPLETED